Alger Concentrated Equity ETF (CNEQ) is a publicly traded the market company. As of May 21, 2026, CNEQ trades at $39.67 with a market cap of $0 and a P/E ratio of 0.00. CNEQ moved +3.58% today. Year to date, CNEQ is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces CNEQ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Alger Concentrated Equity ETF Underperforms; Apple, Natera Top Contributors, QXO’s $2.25 B Deal Looms: The Alger Concentrated Equity ETF underperformed the Russell 1000 Growth Index in Q3 2025, led by top contributors Alphabet, Natera and Apple and detractors Nebius Group, Sea Limited and Meta Platforms. Separately, QXO’s announcement to acquire Kodiak for $2.25 billion may marginally affect ETF performance.
| Metric | Value |
|---|---|
| Price | $39.67 |
| Market Cap | $0 |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $0.00 |
| 52-Week Low | $0.00 |
| Volume | 118.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
CNEQ analyst coverage data. Average price target: $0.00.